Coffee-industry biotech

01Overview and value chain#

Markers EC: FDA novel-ingredient/GRAS pathway for beanless coffee ingredients | OECD: Food systems | Regulator: FDA (USA), EFSA (EU)

Coffee-industry biotech covers two distinct routes to a bean-free cup: fermenting or blending non-tropical ingredients (date seeds, chicory, pea protein) into a beanless coffee that matches conventional flavor and caffeine, and true cell-cultured coffee grown from coffee cells in a bioreactor. Atomo, maker of the “world’s first beanless espresso,” has taken its bean-free coffee to 73 cafes worldwide and made its UK debut at a high-end Mayfair espresso bar. Compound Foods, behind the Minus beanless coffee brand, has moved into B2B with an ingredients platform offering cocoa, coffee and chocolate alternatives to manufacturers seeking to “future-proof” supply chains against global shortages. On the cellular side, Finland’s VTT Technical Research Centre demonstrated drinkable lab-grown coffee in 2021 and is now targeting a commercial cellular coffee product by 2027, with cultivated coffee grown in bioreactors using 98% less water than conventional farming and no agricultural land — though regulatory approval and scaling remain the primary hurdles. A separate cell-culture route pairs Israel’s Coffeesai with Brevel’s illuminated fermentation technology to accelerate cell-based coffee production using light as a key input.

Key directions of coffee-industry biotech:

1. Fermented beanless coffee blends (Fermented Beanless Coffee Blends): non-tropical ingredients (date seeds, chicory, pea protein) processed to replicate coffee’s flavor and caffeine profile without any coffee bean.
2. B2B beanless ingredient platforms (B2B Beanless Ingredient Platforms): originators pivoting from a direct-to-consumer beanless coffee brand to selling the underlying ingredient to food and beverage manufacturers.
3. Cell-cultured coffee in bioreactors (Cell-Cultured Coffee in Bioreactors): true coffee plant cells grown in a bioreactor rather than a field, using a fraction of conventional farming’s water and land.
4. Light-driven cellular coffee fermentation (Light-Driven Cellular Coffee Fermentation): illuminated fermentation technology accelerating cell-based coffee production using light as a process input.

Sectoral value chain#

[ingredient/cell-line sourcing] ──> [fermentation or bioreactor cultivation] ──> [flavor/caffeine matching] ──> [formulation]
                                                                                        │
                                                                                (regulatory
                                                                                 novel-ingredient review)
                                                                                        │
                                                                                        ▼
[cafe/retail/B2B sale] <─── [brand or ingredient distribution] <──────────────────────┘

Value chain levels#

Cross-cutting technologies of the sector:

• Non-tropical ingredient flavor matching (Non-Tropical Ingredient Flavor Matching): processing date seeds, chicory or pea protein to replicate coffee’s specific flavor and caffeine compounds.
• Coffee cell-line bioreactor culture (Coffee Cell-Line Bioreactor Culture): growing coffee plant cells directly in a bioreactor rather than a field.
• Illuminated fermentation (Illuminated Fermentation): using light as a process input to accelerate cell-based coffee production.

02US#

The US hosts the two most retail-advanced beanless coffee originators, one direct-to-consumer and one now pivoting to B2B ingredient supply.

beanless espresso retail expansion, B2B ingredient platform pivot, climate-shortage positioning#

• Atomo Coffee: maker of the “world’s first beanless espresso,” has expanded to 73 cafes worldwide and made its UK debut at a high-end Mayfair espresso bar, positioned against a coffee crop increasingly at risk from climate change.
• Compound Foods: behind the Minus beanless coffee brand, launched a B2B ingredients platform offering fermentation-based cocoa, coffee and chocolate alternatives to manufacturers seeking to future-proof supply chains against global shortages.

03CN#

Public information on a dedicated Chinese coffee-industry biotech originator was not confirmed with company-specific detail in this pass; the section stays at the policy level.

national biotech-manufacturing policy context, no confirmed company-specific detail this pass#

• National biotech-manufacturing policy context: regional press coverage frames China as aiming to become a global hub for biotechnology-based manufacturing broadly, a context that could extend to coffee-industry biotech without a confirmed dedicated originator.
• No confirmed company-specific detail this pass: the Chinese candidate investigated in this pass returned a postdoctoral-recruitment listing and general biotech-industry commentary rather than a source confirming a specific coffee-biotech company’s current activity.

04EU#

Finland and the Netherlands anchor the region’s activity, spanning a research-institute-led cellular coffee program and a beanless coffee originator built on non-tropical ingredients.

cellular coffee bioreactor research, 2027 commercialization target, non-tropical beanless coffee ingredients#

• VTT Technical Research Centre of Finland: demonstrated drinkable lab-grown coffee in 2021 and is targeting a commercial cellular coffee product by 2027, with coffee cells grown in bioreactors using 98% less water than conventional farming and no agricultural land, though regulatory approval and scaling remain the primary hurdles.
• Northern Wonder: a Netherlands-based originator making “coffee-free coffee” from non-tropical ingredients such as date seeds, pea protein and chicory, aiming to combat tropical deforestation without compromising taste.

05Leading companies and research institutes#

06Tech stack and innovations#

The stack replicates coffee’s sensory and chemical profile through fermentation or cell culture rather than agriculture.

1. Non-tropical ingredient fermentation (Non-Tropical Ingredient Fermentation):
   • date seeds, chicory and pea protein are processed and fermented to replicate coffee’s specific flavor compounds and caffeine content.
   • case: Northern Wonder and Atomo both build their beanless coffee around non-tropical ingredient processing rather than any coffee-plant material.
2. Cell-cultured bioreactor coffee (Cell-Cultured Bioreactor Coffee):
   • coffee plant cells are grown directly in a bioreactor, cutting water use by 98% versus conventional farming and eliminating the need for agricultural land.
   • case: VTT’s cellular coffee program is explicitly targeting a 2027 commercial product on this basis.
3. Illuminated cell-culture acceleration (Illuminated Cell-Culture Acceleration):
   • light is used as a direct process input to accelerate cell-based coffee production.
   • case: Coffeesai’s partnership with Brevel applies illuminated fermentation technology specifically to speed up cell-cultured coffee output.

07Value chains and production pipelines#

Industrial pipeline of a beanless/cellular coffee product (FDA/EFSA novel-ingredient review)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Ingredient/cell-line sourcing│ ───> │ 2. Fermentation or bioreactor cultivation│
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Regulatory review      │ <─── │ 3. Flavor/caffeine matching│
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Formulation            │ ───> │ 6. Cafe/retail/B2B sale   │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Ingredient/cell-line sourcing

Non-tropical ingredients (date seeds, chicory, pea protein) or a coffee plant cell line are procured.

Stage 2: Fermentation or bioreactor cultivation

The ingredient blend is fermented, or coffee cells are cultured directly in a bioreactor.

Stage 3: Flavor/caffeine matching

The output is processed and matched against conventional coffee’s specific flavor and caffeine profile.

Stage 4: Regulatory review

The product clears FDA novel-ingredient/GRAS review or EU novel-food authorization before sale.

Stage 5: Formulation

The flavor-matched base is formulated into a finished beverage or a B2B ingredient for manufacturers.

Stage 6: Cafe/retail/B2B sale

The product reaches consumers through cafes and retail, or manufacturers through a B2B ingredient platform; cellular coffee remains earlier-stage, still working through Stage 4 ahead of its targeted 2027 commercial launch.